Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.255 USD | +0.16% | -0.72% | -28.79% |
Mar. 27 | MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products | MT |
Mar. 27 | MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.79% | 922M | |
-20.60% | 129M | |
-12.72% | 61.39M | |
+6.64% | 60.85M | |
+0.60% | 51.57M |
- Stock Market
- Equities
- MDXG Stock
- News MiMedx Group, Inc.
- Insider Trends: MiMedx Group Insider Gets Stock Award, Extends Buy Trend